3DPrint.com July 19, 2024
3D printing software and service pioneer Materialise (Nasdaq: MTLS) has bought FEops, a cardiac care software package developer that uses AI to simulate and predict outcomes of cardiac procedures. Specifically, FEops deals with transcatheter structural heart devices. Structural heart diseases can include congenital conditions or issues like coronary artery disease and hypertrophic cardiomyopathy, a thickening of heart tissue leading to less blood being pumped. When devices are used to ameliorate these conditions, they generally have to be customized to work well. In the case of heart valves, treatment could involve putting a balloon inside to open the area or major surgery to replace the valve by opening up the chest. A newer set of procedures includes TAVR, also called Transcatheter...
Today's Sponsors
Today's Sponsor